page: 2 of 10 | items: 4 to 6 | previous | next

01.08.2016
6th Global Reverse Phase Protein Array Workshop
 
[more...]

02.05.2016
Sentinel Oncology and NMI TT Pharmaservices awarded Eurostars grant for development of a novel biomarker for treatment of Fragile X Syndrome

[more...]

09.01.2016
Product Launch: new Cav1.2 cell line
Cav1.2 ion channels are expressed in heart, smooth muscle and neurons, and therefore are therapeutic targets in cardiac arrhythmia and hypertension.

[more...]